Exclusive

Publication

Byline

Location

US Patent Issued to Novartis on April 21 for "Targeted plasma protein degradation" (Massachusetts Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,451, issued on April 21, was assigned to Novartis AG (Basel, Switzerland). "Targeted plasma protein degradation" was invented by Martin Al... Read More


US Patent Issued to Regents of the University of Minnesota, Regents of the University of California on April 21 for "Compounds that degrade kinases and uses thereof" (Minnesota, California Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,452, issued on April 21, was assigned to Regents of the University of Minnesota (Minneapolis) and Regents of the University of California (... Read More


US Patent Issued to Industry-University Cooperation Foundation Hanyang University, Konkuk University Glocal Industry-Academic Collaboration Foundation, Korea National University of Education Industry-Academy Cooperation Foundation on April 21 for "CP2C-targeting peptide-based anticancer agent" (South Korean Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,453, issued on April 21, was assigned to Industry-University Cooperation Foundation Hanyang University (Seoul, South Korea), Konkuk Univers... Read More


US Patent Issued to SAIBA on April 21 for "Modified virus-like particles of CMV" (Latvian, Swiss Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,454, issued on April 21, was assigned to SAIBA AG (Pfaffikon, Switzerland). "Modified virus-like particles of CMV" was invented by Martin ... Read More


US Patent Issued to Vascular Biosciences on April 21 for "CAR peptide for improved coronavirus survival" (California Inventor)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,455, issued on April 21, was assigned to Vascular Biosciences (San Diego). "CAR peptide for improved coronavirus survival" was invented by... Read More


US Patent Issued to Utah Valley University on April 21 for "Composition and method for HIP1-targeting inhibitor compounds" (Australian, American, Spanish Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,456, issued on April 21, was assigned to Utah Valley University (Orem, Utah). "Composition and method for HIP1-targeting inhibitor compoun... Read More


US Patent Issued to BLISS BIOPHARMACEUTICAL (HANGZHOU) on April 21 for "Modified EGFR antibody with reduced affinity, drug conjugate, and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,457, issued on April 21, was assigned to BLISS BIOPHARMACEUTICAL (HANGZHOU) Co. LTD. (Hangzhou, China). "Modified EGFR antibody with reduc... Read More


US Patent Issued to SYSTIMMUNE on April 21 for "Antibody-drug conjugate having acidic self-stabilization junction" (Chinese Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,458, issued on April 21, was assigned to SYSTIMMUNE INC. (Redmond, Wash.). "Antibody-drug conjugate having acidic self-stabilization junct... Read More


US Patent Issued to REGENERON PHARMACEUTICALS on April 21 for "Protein-drug conjugates comprising camptothecin analogs and methods of use thereof" (Delaware Inventor)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,459, issued on April 21, was assigned to REGENERON PHARMACEUTICALS INC. (Tarrytown, N.Y.). "Protein-drug conjugates comprising camptotheci... Read More


US Patent Issued to GACHON UNIVERSITY OF INDUSTRY-ACADEMIC COOPERATION FOUNDATION on April 21 for "Stem cell-nano drug delivery system complex, use thereof and method for preparing the same" (South Korean Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,460, issued on April 21, was assigned to GACHON UNIVERSITY OF INDUSTRY-ACADEMIC COOPERATION FOUNDATION (Seongnam-si, South Korea). "Stem c... Read More